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Abstract
Purpose—Glaucoma is a leading cause of blindness in people of African descent. Minimal data
is available from African population-based cohort studies. The primary aims of this study were to
describe the normative distribution of glaucoma features to enable glaucoma classification and to
assess risk factors for those with glaucoma at follow-up among people aged ≥50 years in Kenya.
Materials and Methods—Random cluster sampling with probability proportionate to size was
used to select a representative cross-sectional sample of adults aged ≥50 years in 2007-8 in
Nakuru District, Kenya. A six-year follow-up was undertaken in 2013-14. Comprehensive
ophthalmic examination included visual acuity, digital retinal photography, visual fields, intra-
ocular pressure, OCT and independent grading of optic nerve images. We report glaucoma
features, prevalence and predictors for glaucoma based on the ISGEO criteria. Measures were
estimated using a Poisson regression model and including inverse-probability weighting for loss to
follow up.
Results—At baseline, 4,414 participants aged ≥50 years underwent examination. Anterior
chamber OCT findings: mean anterior chamber angle of 36.6°, mean central corneal thickness of
508.1µm and a mean anterior chamber depth of 2.67mm. 2,171 participants were examined at
follow-up. The VCDR distribution was 0.7 and 0.8 at the 97.5th and 99.5th percentiles,
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respectively. A total of 88 (4.3%, 95% CI, 3.5-5.9%) of participants at follow-up had glaucoma
consistent with ISGEO criteria. A RAPD and raised IOP were associated with the diagnosis.
Conclusions—Glaucoma is a public health challenge in low-resource settings. Research into
testing and treatment modalities in Africa is needed.
Keywords
Africa; glaucoma; optic nerve; Cohort; Population-based
Introduction
Glaucoma is a leading cause of blindness globally.1 The proportion of the worldwide
magnitude of blindness attributable to glaucoma increased by 50% between 1990 and 2010
from 4.4% to 6.6%.2 This trend is expected to continue over coming decades, with the
estimated numbers with glaucoma predicted to rise from 60.5 million people in 2010 to 79.6
million by the year 2020 3 and then to 111.8 million by 2040.4 Glaucoma is the second most
common cause of blindness in sub-Saharan Africa (SSA),5 with estimates suggesting that
there were 6.5 million people with glaucoma in SSA in 2010 projected to increase to 8.4
million by 2020, though data are sparse.6
Whilst blindness from glaucoma may be preventable, this is dependent upon early diagnosis
and delivery of long-term effective treatment. Glaucoma poses a particular problem in sub-
Saharan Africa due to both higher age-specific prevalence, higher risk for open-angle
glaucoma,7–10, late presentation11 and low levels of coverage and adherence with
treatment.12, 13 Adherence to topical treatment is sufficiently poor that the primary
treatment of choice in SSA is often surgery5 in the hope that a single intervention achieves
long term control of intra-ocular pressure (IOP) as the main modifiable risk factor. 11–13
Furthermore, clinical features of glaucoma may be different in a sub-Saharan African setting
compared to elsewhere, necessitating different therapeutic approaches.
The objectives of this study were, within the context of a population-based cohort study in
Nakuru, Kenya: i) to describe normative features of glaucoma in this cohort, ii), to describe
the prevalence of glaucoma or specific glaucoma features at baseline and at follow up, iii) to
assess baseline risk factors for having glaucoma at follow up and iv) to describe clinical
signs predictive of glaucoma at follow up. 14 The distribution of key features of glaucoma
(optic nerve morphology, intraocular pressure, visual acuity, angle morphology) and the risk
factors associated with changing optic disc morphology that occurred over the six year
follow up period will also be described.
Materials and Methods
Ethics Statement
The London School of Hygiene & Tropical Medicine (LSHTM) Ethics committee and the
African Medical Research Foundation (AMREF) granted ethical approval for the study.
Approval was also granted by the Provincial Medical Officer for Nakuru County. Written
approval was sought from the administrative heads in each cluster, usually the village chief.
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All participants gave written or thumbprint consent to participate. People requiring medical
treatments were referred to the appropriate health care service.
Sampling Strategy and Recruitment
The study baseline fieldwork was carried out between January 2007 and November 2008.
The follow-up study took place between October 2012 and March 2014. At baseline, 100
clusters were selected across Nakuru County with a probability proportional to the size of
the population using the electoral roll as the sampling frame. A cluster was defined as the
area served by a polling station. Households were selected within clusters using a modified
compact segment sampling method 15. Each cluster was divided into segments so that each
segment included approximately 50 people aged ≥50 years. One segment was selected at
random, and all eligible people were included sequentially until 50 had been examined.
The sample size of 5000 people was sufficient to estimate a prevalence of disease at 3.0%
among those aged ≥50 years, with a required precision of 0.5%, 95% confidence, a design
effect to account for clustering of 1.5, and a response rate of 90% (Epi Info 6.04, Centers for
Disease Control and Prevention, Atlanta, GA). In total, 4,381 participants were recruited at
baseline (response rate 81%). All participants were invited to attend an examination clinic at
a central location within the cluster (see below).
Follow-up
Approximately one week before the follow-up examination clinic was carried out for a given
cluster, a field officer studied the maps of the village including GPS coordinates recorded at
baseline and made phone contact with the village chief or guide to arrange the visit. At the
planning visit a list of study participants were given to the chief and a local village guide
was recruited to assist locating the study participants. Two days prior to the clinic, the field
officer reminded chiefs of the visit by phone and notified them and the guide of the advance
team’s arrival. On the day prior to the examination clinic, a study team visited homes of
baseline participants and confirmed their identity using National Identity cards and invited
them to attend the examination clinic the following day. All identified participants were also
asked to help locate baseline participants that had not been found.
On the examination day, the advance team confirmed the identity of participants against data
from baseline (age, date of birth, name, and identity cards). In cases of uncertain identity,
confirmation was made based on retinal examination verified by comparison of retinal
photos with baseline photo (n=12).
In both baseline and follow-up, an examination clinic was established at a central location
where there were appropriate amenities such as electricity, water and road access. The
following examination protocols were implemented at both baseline and follow-up. 14, 16
Ophthalmic and General Examination
Visual Acuity—All participants at baseline and follow-up underwent visual acuity testing
on each eye separately at four meters using a reduced LogMAR tumbling ‘E’ chart17 in an
appropriately illuminated area, as described elsewhere.18, 19 The presenting visual acuity
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was defined as the number of letters read correctly without glasses if the participant did not
have glasses, or with glasses if they had them.
Anterior Segment Examination—At baseline the anterior segment assessment was
made on the slit lamp by a single ophthalmologist (WM). The Van Herick angle assessment
was performed. 20
Anterior Chamber OCT—Gonioscopic assessment of the angle was not undertaken,
however a Heidelberg Slit Lamp-adapted Optical Coherence Tomography (SL-OCT)
(Heidelberg Engineering, Heidelberg, Germany) was used at baseline to examine the
anterior segment to provide population normative data on the Angle Opening Distance
(AOD), Anterior Chamber Angle (ACA), Central Corneal Thickness (CCT) and Anterior
Chamber Depth (ACD). These normative data analyses excluded eyes that were
pseudophakic. Furthermore, eyes with trachomatous or non-trachomatous corneal opacities
and those with disorganized globes (phthisis, staphyloma) were excluded from the corneal
thickness analysis. All measurements were obtained from scans using the interactive
distance measurement of the SL-OCT proprietary software (Heidelberg Eye Explorer
v1.5.9.0; Heidelberg Engineering, Heidelberg, Germany). Analyses based on naso-temporal
(horizontal) meridians. Anterior chamber depth was assessed using peaks of the corneal
reflectivity profile to identify the central cornea as well as the anterior and posterior
boundaries of the cornea. Calipers were aligned from the posterior border of the central
cornea. Two measurements were averaged for each eye. Anterior chamber angle opening
distance was taken as posterior cornea and opposite peripheral iris with the apex lying in the
angle recess. All anterior segment measurements were taken with the pupil undilated.
Gonioscopy
At follow-up, an assessment of the opening angle of participants’ right and left eyes using
direct visualisation was made using a four-mirror gonioscopy lens (Zabbys). This lens does
not require coupling fluid and was chosen to minimize impact on the quality of retinal
photographs. Angles were recorded using standard Shaffer grading and further classified as
“open”, “occludable” or “closed” based on standard referral criteria. 21 Angle OCT was not
performed at follow-up. Occludable angles were defined at follow up as: pigmented
trabecular meshwork not visible in 3/4 or more of angle circumference in primary position
without manipulation, in presence of low illumination. If the patient could not cooperate
with gonioscopy, the Van Herick (VH) technique 20 was used for grading with an anterior
chamber depth of less than quarter of the corneal thickness being considered occludable.
Intraocular Pressure (IOP)—At baseline and follow-up participant’s eyes were
anesthetized using tetracaine 1% eye drops (Kenya Society for the Blind, Eye Drop
Production Unit, Nairobi, Kenya) and the tear film stained with fluorescein-impregnated
paper. IOP was measured using a Goldmann Applanation Tonometer. One reading was taken
from each eye and analysed independently. The tonometer was checked for calibration
weekly and disinfected between patients.
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Visual Field Assessment—At baseline, all individuals with suspect or abnormal discs
on clinical slit-lamp examination underwent automated visual field testing. The Humphrey®
Field Analyzer II - 720i series (Carl Zeiss Ophthalmic Systems, Oberkochen, Germany) was
used. A suspect or abnormal disc was defined as a vertical cup to disc ratio (VCDR) of 0.7
or above; optic disc cupping asymmetry between the eyes of more than 0.2 VCDR; or any
other abnormal features including notching, disc haemorrhages or disc pallor. A random
sample of five individuals per cluster (10%) also underwent visual field testing to provide
normative data.
Participants performed the Swedish Interactive Thresholding Algorithm (SITA)
STANDARD 24-2. SITA Fast was used to determine the threshold level in all participants
having visual field analysis. Appropriate corrective lenses for refractive errors were used
when needed. An automated fixation monitor was used throughout. If the SITA fast test was
reliable the SITA standard test was performed. If the SITA fast was unreliable (false-
positives, ≥20%; false-negatives, ≥33%; fixation losses, ≥33%), then this was repeated once.
If it remained unreliable then no further testing was done.
At follow-up, a different strategy for visual field testing was used due to challenges at
baseline: All subject’s eyes with VA equivalent to >=6/60 Snellen underwent automated
visual field testing by a trained visual field technician using the Henson 8000 Visual Field
Analyser (TopCon, Tokyo, Japan) The multiple stimulus suprathreshold test was used
following manufacturers guidelines (Screening test - 26 test locations). When one or more
spots were missed, the 26-point test was repeated for that eye. If any missed spots re-
occurred on the second time of testing the test for that eye was extended to 68 test locations.
This machine and strategy were used in preference to the baseline methods due to feedback
from both patient’s and tester at baseline as well as unreliable visual field data from
baseline. Patient’s found the baseline testing protocol difficult to understand and the time
required to complete the test meant only a sub-sample of the population could be
investigated.
Visual fields were considered consistent with glaucoma at baseline and follow-up if:
(1) The test was reliable according to performance indices
(2) The glaucoma hemifield test was outside normal limits, and
(3) The test showed three or more abnormal contiguous points clustering in the
same hemi field.
Visual Fields were graded at the Moorfields Eye Hospital Reading Centre.
Fundus photography and grading
The participants had two non-stereoscopic digital 45° fundus photographs taken per eye by
an ophthalmic clinical officer using a TRC-NW6S Non-Mydriatic Retinal Camera with 10
megapixel Nikon D80 (TopCon, Tokyo, Japan) at baseline and a DRS CentreVue+ (Haag-
Streit, Köniz, Switzerland) Retinal Camera at follow-up. One image was centered on the
optic disc while the other was centered on the macula.
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The digital images were forwarded to the Retinal Grading Centre at Moorfields Eye Hospital
Reading Centre (MEHRC) London for grading and confirming the clinical diagnosis of
posterior segment disease.
The senior grader graded all discs considered abnormal on clinical examination at the
slitlamp at baseline and all optic nerve images at follow-up. Images were first categorized
for quality as excellent, good, fair, borderline or ungradeable. They were then graded for
vertical cup disc ratio (VCDR). The scleral ring was identified to determine the margins of
the disc and delineating the rim identified the cup. The rim was defined as the area between
the border of the optic disc and the position of blood vessel bending and the area within the
rim as the cup. A vertical measure of both the cup and disc were taken to calculate the
VCDR. Discs images were also examined for any abnormality and were graded as normal,
suspicious or abnormal. A disc was deemed abnormal if any of neuro-retinal rim (NRR)
thinning, notching or disc hemorrhage(s) were present, if VCDR was ≥0.7. A suspicious disc
was one where adjudication was necessary to determine if its appearance was abnormal.
In case of difficulties, the adjudicator (TP) decided on the grading of the images. The
adjudicator also graded 5% of randomly selected images to ensure quality control.
At baseline and follow-up, all participants’ discs were estimated based on image grading.
Data Handling & Statistical Analyses Methods
Data entry—Image data were double entered into a specially developed dataset (EpiData
Entry v 2.1) at both baseline and follow up. Consistency checks were performed each
evening and inconsistencies corrected the same day.
Data analysis—The International Society for Geographical & Epidemiological
Ophthalmology (ISGEO) categorises glaucoma as Primary Open Angle Glaucoma (POAG)
and Primary Angle Closure (PAC) based on direct viewing of the angle. POAG is defined in
three categories based on the optic nerve VCDR, visual fields, IOP, VA and the presence or
absence of previous glaucoma surgery (clinically or from medical records). 22 The mean,
97.5th and 99.5th percentiles were calculated for optic disc VCDR and IOP for the
participants at follow-up. Based on baseline normative data, the cut-off points required for
ISGEO POAG classifications were used to classify accordingly: 22
• Category 1 with structural and functional evidence: Eyes with a VCDR
or VCDR asymmetry ≥97.5% for the normal population that showed a
definite visual field defect consistent with glaucoma.
• Category 2 (advanced structural damage with unproven field loss):
Eyes of those without any or with no valid visual field testing but with a
VCDR or asymmetry ≥99.5th percentile for the normal population.
• Category 3 (no view of optic disc and field testing impossible): Eyes of
those with VA<3/60 and the IOP>99.5th percentile, or VA<3/60 and
evidence of glaucoma filtering surgery, or previous diagnosis of glaucoma
confirmed from medical records.
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Glaucoma suspects were defined as:
- field suspects: those with abnormal visual fields consistent with glaucomatous
changes but no raised IOP, disc damage or features consistent with trabecular
obstruction,
- disc suspects: those with VCDR ≥97.5th percentile for the population but less
than the 99.5th percentile and no other feature of glaucoma and no documented
field defect. It also included those with optic disc hemorrhages accompanied
by no other feature of glaucoma
- Ocular Hypertensives: IOP ≥97.5th percentile with normal optic disc and
normal visual field
A normative sample was used to calculate the 97.5th and 99.5th percentiles of VCDR and
IOP from those participants examined at follow-up with normal visual fields.
Baseline to follow-up changes
It was not possible to produce an annual glaucoma incidence due to the lack of reliable
visual field data and therefore it was not possible to define an “at-risk” baseline group.
Individuals at follow-up were classified as suspect or definite glaucoma -based on ISGEO
criteria using graded images of the optic disc and visual fields. Participants at follow-up
were then classified in a binary manner as normal or glaucoma (glaucoma if ISGEO
categories 1, 2 or 3 were fulfilled for that participant). Multivariable logistic regression
analyses were conducted to compare those with and without features of glaucoma at follow-
up in terms of baseline demographic, anthropometric and ocular features as potential risk
factors of glaucoma.
Results
Follow up rates
At baseline (2007-2008), 4,414 participants had a complete assessment and of these, 2,171
(50%) were seen at follow-up six years later. Characteristics of participants and non-
participants at follow-up are described in detail elsewhere.23, 24 In summary, compared
with those followed-up, participants who had died during follow-up were older, more likely
to be male, to have lower education levels and higher systolic blood pressure and have
diabetes, but had lower BMI. Compared with participants seen, those lost to follow-up (not
known to be deceased) were less likely to be Kikuyu or Kalenjin speakers, had lower levels
of education, and were more likely to be from urban areas and be from either the highest or
lowest socioeconomic quartile.
Anterior Chamber OCT
Anterior segment findings at baseline using OCT are described in Table 1, the mean angle
opening distance (n=6,259) was 631µm (SD:167), the mean anterior chamber angle
(n=3,484) was 36.6° (SD:7.6), the mean central corneal thickness (n=6,365) was 508.1 µm
(SD:36.9), and the mean anterior chamber depth (n=6,358) was 2.67mm (SD:0.32)
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Gonioscopy
Anterior Segment OCT was not available at follow-up, however 2,111 right eyes and 2,107
left eyes had a direct visualisation of the angle using a 4-mirror gonioscope, with only five
right and five left eyes (0.2%) considered to have occludable angles (based on visualisation
of Schwalbe’s line and the anterior meshwork or less); see Table 2.
Intraocular Pressure
The mean IOP at baseline based on 3,745 observations (right eye only) was 15.3mmHg (SD
3.4, Range 2-46mmHg). Of these, there were 1,775 observations (right eyes only) for whom
IOP was measured at both baseline and follow-up. Among these, at baseline mean IOP was
15.4 (SD 3.4) for the right eye, and at follow-up (right eyes) was 15.0mmHg (SD 3.2, Range
= 1-34mmHg), providing evidence of a lower IOP at follow up compared to baseline among
right eyes (p<0.001). IOP was significantly higher in the right eye than the left eye at both
baseline (p<0.001) and follow-up (p=0.02). See Table 3.
Optic discs
At baseline, due to camera failure preventing image acquisition in one third of clusters, a slit
lamp based clinical assessment of the optic disc vertical cup to disc ratio (VCDR) was made
in two ways:
1. Through undilated pupils with +90D lenses using slit lamp biomicroscopy
(n=5,917 eyes)
2. After dilating pupils with +90D lenses using slit lamp biomicroscopy
(n=7,821 eyes)
Baseline optic disc assessment is summarised in Table 4.1,063 (25.7%) Right Eye discs and
1,078 (25.8%) Left Eye Discs could not be visualised with undilated pupils. There was a
statistically significant difference between the mean VCDR for eyes with pupils dilated and
non-dilated pupils where the disc was visible in both instances, with the dilated eyes having
higher VCDR ratios (0.23, SD 0.15) than non-dilated eyes (0.21, SD 0.13) (paired t
test<0.001). Using undilated CDR 1.5% of eyes had CDR≥0.7 while using dilated CDR,
2.8% of eyes had VCDR≥0.7 (X2=13.8 p=0.002).
At follow up, the VCDR for right and left eyes from image grading were available in all
clusters from 3,658 of a possible 4,342 eyes (2,171 people). The median VCDR was 0.3 and
at the 97.5th and 99.5th percentile it was 0.7 and 0.8 respectively. See Figure 1.
The VCDR percentiles at follow-up in those with a normal visual field (n=1062) remained at
0.7 and 0.8 at the 97.5th and 99.5th percentiles respectively.
At baseline, 3,251 participants had a clinical assessment (i.e. no image grading) of the optic
discs, of which 40 (1.2%) were considered abnormal, 536 (16.5%) suspicious and 2,675
(82.3%) normal. At follow-up, 2,003 participants had an image-based assessment of the
optic discs, of which 64 (3.2%) were graded as abnormal, 234 (11.7%) suspicious and 1,705
(85.1%) were normal. 89 of 1,255 (7.1%) participants who had a baseline (clinical) and
follow-up (image) assessment went from “normal” to either “suspicious” or “abnormal”. Of
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the 1,499 participants who had optic discs graded at both baseline (clinical) and follow-up
(image) 17l (1.1%) were considered abnormal, 236 (15.7%) suspicious and 1246 (83.1%) as
normal at baseline. At follow up there were 53 (3.5%) considered abnormal, 174 (11.6%)
suspicious and 1272 (84.9%) normal.
Visual Fields
Interpretation based on visual fields was not possible at baseline. A total of 508 participants
(glaucoma suspects and non-glaucoma suspects) were indicated for visual field testing at
baseline of whom 342 (67.3%) completed the test on the Humphrey Visual Field Analyser.
Of these, 63.2% and 69.1% of normal and glaucoma suspects had abnormal visual field
results despite good reliability indices. These baseline results were therefore discarded.
At follow-up, 1,309 (60.3%) participants successfully completed fields on the Henson 8000
Field Analyser with reliable results. 1,074 (82.0%) were normal in both eyes, 122 (9.3%)
had one or both eyes with suspicious fields and 113 (8.6%) had an abnormal field in one or
both eyes.
Based on gradable optic disc images at follow-up in those with normal visual fields, the
97.5th and 99.5th percentile VCDRs were 0.7 and 0.8 respectively (Figure 1).
Signs of glaucoma
At follow-up, 1,246 individuals had a VF measurement and a disc grading. Of these, 895
(71.8%) had both a normal VF and a normal disc, 141 (11.3%) had a normal VF and
suspicious or abnormal disc, 182 (14.6%) had a suspicious or abnormal VF and normal discs
and 28 (2.2%) had both suspicious or abnormal VFs and suspicious or abnormal discs.
Using the ISGEO classification 88 participants were considered to have glaucoma based on
meeting either the ISGEO 1 (n= 64), 2 (n=22) or 3 (n=2) criteria, 1,973 participants did not
meet ISGEO criteria and were deemed non-glaucoma, 110 could not be classified (Figure 2).
Based on follow up optic disc grading from images, visual fields, IOP and visual acuity,
participants were defined as glaucoma positive or negative based on the ISGEO criteria.
Vision status comparing participants with and without ISGEO glaucoma are described in
Table 5 showing participants with glaucoma were more likely to have visual impairment.
85.2% of the non-glaucoma group classified as normal vision, compared to 72.7% in the
glaucoma group. Blindness and VI were more prevalent in the glaucoma group, 5.7% and
21.6% respectively compared to those without glaucoma, 1.2% and 13.6% respectively.
Baseline and follow-up risk analyses was conducted and is summarised in Table 6. There
was some evidence of an association of glaucoma with gender (male as baseline, Female
OR=0.69, 95%CI: 0.45-1.06, p=0.10). No evidence of an association was found between
baseline IOP and BMI (p=0.49), height (p=0.58) and weight (p=0.28). Associations of
glaucoma with ophthalmic signs at follow-up were seen for both IOP (IOP>21mmHG OR:
4.10 (95%CI, 2.08-8.08), p<0.001) and a relative afferent pupillary defect (RAPD) showing
a particularly strong association with being categorised as glaucoma (Confirmed RAPD OR:
7.39 (4.20-13.01), p<0.001).
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Discussion
In this study we have described the population distributions and normative ranges from an
epidemiological survey of glaucoma in an East African population in Kenya. Structural
damage manifest by optic nerve changes was comparable in terms of the population
distribution to other studies (described below). In those with glaucoma at follow-up, the
strongest predictors were the presence at follow-up of an RAPD and IOP above 21mmHg.
No demographic or anthropometric risk factors were associated with glaucoma.
The prevalence of glaucoma on those followed up was 4.3% (CI, 3.5-5.9) which is
comparable to other population based studies in Africa which range from 4.2% (3.5-4.9) to
7.3% (5.5-9.1)25, 26 with a higher prevalence in west African populations (Nigeria 5.0%
(4.6-5.5) and 7.3% (5.5-9.1),26 Ghana 6.5% (5.8-7.1)27) than is East and Southern African
populations (Tanzania 4.2% (3.5-4.9),25 South Africa 4.5% (3.2-6.1)28 and 5.3%
(3.9-7.1)29).
The basis of the diagnosis of glaucoma in the majority of cases, both in clinical settings and
in population based surveys, is correlation of structural optic nerve damage and loss of
function demonstrated by visual field testing.30 However, in SSA, where equipment
constraints are considerable,31 visual field testing is not widely available. A survey in Lagos
State, Nigeria identified one visual field analyser for every 2,380,000 population including
private and governmental facilities. 32 Even where field analysers are available, they are of
much less importance in the diagnosis and treatment decision making process than in more
resource intense settings; visual field changes were a factor in only 4% of treatment
decisions in a review of 344 patients attending a glaucoma clinic in South African.33
Population based studies have demonstrated that there are substantial difficulties in
achieving adequate field testing in SSA populations.34
The lack of a reliable visual field in the baseline of this cohort is consistent with other
studies in the region that have faced similar challenges such as the Nigerian National
Blindness Survey that used a relatively simple testing modality, the Humphrey Frequency
Doubling Technology test, where adequate testing was only available for 60% of 4,538
Nigerian patients.34 Furthermore, the logistical problems obtaining reliable visual field tests
mean that they were not included in the flow chart for community diagnosis of glaucoma in
a recently published West African algorithm; relative afferent pupillary defect testing was
the chosen test of nerve function,35 which the findings of this study concur with.
Diagnosis and management of glaucoma in SSA, therefore, centres very much around IOP
and optic nerve assessment, the latter through direct visualisation and pupil assessment. Very
little data from longitudinal population-based cohorts exist, with none to date from SSA, on
glaucoma. This cohort study of people aged 50+ undertaken in Nakuru, Kenya, with
baseline in 2007-8 and follow-up in 2013-14 was an opportunity to estimate the normative
range of various features of glaucoma as well as potential features that are important for
clinical decision making in a context where availability of equipment is limited.
The percentile distributions of optic nerve VCDR and IOP in the Nakuru Cohort follow-up
subgroup in whom image grading was available was very similar to the Nigeria National
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Blindness survey, a nationally representative survey of adults 40 years and older, which is to
our knowledge the only National survey in SSA to derive percentile values for defining
glaucoma in population-based surveys.36 At the 97.5th and 99.5th percentiles the VCDR in
Kenya was 0.7 and 0.8 respectively and 0.75 and 0.95 in Nigeria (in all the population with
gradable disc images). The median VCDR was lower in Kenya at 0.23 compared to 0.4 in
Nigeria.36 Our findings are also consistent with other population-based studies in the region
where a VCDR of 0.7 was consistent at the 97.5th percentile however greater variation is
found at the 99.5th from 0.7 in Tanzania to 0.9 in South Africa. 27, 29, 37, 38
The IOP distribution in Kenya was similar at baseline and follow-up with a higher median
than in Nigeria (15 vs. 14mmHg) but lower IOP at the 97.5th and 99.5th percentiles (Kenya:
22, 27mmHg vs. Nigeria: 24, 34mmHg).36
Changes over the period of the cohort were difficult to define conclusively due to the
clinical nature of a glaucoma diagnosis, however a strong association between optic discs
and visual fields considered to be outside of normal range was demonstrated, in particular
with the relative afferent pupil defect (RAPD) test. An IOP over 21mmHg was also less
strongly associated with glaucoma as defined by the ISGEO criteria in this study. The
findings suggest a combination of optic nerve assessment by both visualisation including
VCDR grading as well assessing function through the RAPD test are practical means for
identifying individuals who have or are at risk of sight loss from glaucoma. Portable tools
for assessing vision 39 and optic disc imaging 40 may make this more accessible with IOP
being a suitable method to monitor an effect from treatment and various handheld tools now
available for accurate IOP assessment independent of a slit lamp.
Management of glaucoma remains a major challenge in SSA with limited availability and
poor adherence to medical treatment when available. A primary surgical approach has
problems also, in that patients presenting due to visual loss in one eye need to be persuaded
to undergo surgery, most frequently with direct financial costs to them, in the other eye
which they do not as yet consider to have a problem. 11, 41 The operation of choice,
trabeculectomy augmented by anti-metabolites, does not improve the vision in most cases,
but in fact can lead to visual acuity reduction. Identification of new treatment options in
Africa therefore remains a priority.
Strengths of this study included it being a large, population-based sample, representative of
a population on which there is minimal data. A senior ophthalmologist examined all study
participants at baseline and follow up. High quality, modern, equipment was used
throughout.
Limitations included a high loss to follow up (50%) at six years, this was primarily due to
post-election violence affecting the study population with large numbers of people displaced
or killed. Major variations in baseline and follow-up data collection protocols were
employed, in part due to challenges at baseline such as unreliable visual field data, retinal
camera break down and due to a lack of availability of all baseline equipment at follow-up,
e.g. no repeat AC-OCT was undertaken. Key measurement differences and therefore
potential measurement bias were i) likely with visual fields at baseline being completed for
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glaucoma suspects (n=165) and a sub-set of normal participants (n=343) (11.6% of all
baseline participants) only and using a Humphrey field analyser with outputs that could not
be confidently used to make an assessment of glaucoma, the Henson 8000 was used at
follow-up, ii) anterior chamber angle assessment at baseline was based on AC-OCT and on
4-mirror gonioscopy at follow-up, iv) a statistically significant variation between right and
left eye IOP at baseline and follow up. IOP was on average higher in the right than the left
eye at both baseline and follow-up. This may have arisen because the right eye was tested
first and/or because the majority of the population was assumed to be right-handed, and IOP
measurement is associated with hand dominance. 42, 43
In conclusion, glaucoma remains a public health concern. However, the lack of cost-
effective treatments and challenges identifying high-risk individuals means that population-
based screening for open-angle glaucoma should not currently be recommended.44 Further
research in to the risk factors, natural history and aetiology of glaucoma in Africa and the
barriers to effective sight loss prevention are required.
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Figure 1.
The distribution of VCDRs at follow up from retinal images
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Figure 2.
The ISGEO Classification of the Nakuru Eye Disease Cohort follow-up group
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Table 1
OCT Summary of normative findings of the anterior segment at baseline (in those without glaucoma)
Right Eye Left Eye Both eyes
N 3115 3144 6259
Mean Angle Opening Distance (µm) (SD) 620(164.5) 637(179.5) 631(167.3)
N 1774 1807 3484
Mean Anterior Chamber Angle (SD) 36.3(7.7) 37.0(7.5) 36.6(7.6)
N 3179 3186 6365
Central Corneal Thickness (µm) (SD) 507.7(35.7) 508.5(38.1) 508.1(36.9)
N 3177 3181 6358
Anterior Chamber Depth (mm) (SD) 2.66(0.32) 2.68(0.32) 2.67(0.32)
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Table 2
Gonioscopic grading of the angle in the follow-up of the Nakuru Eye Disease Cohort Study
Gonioscopic visualisation (Grade) Right Eye Left Eye
Nil (0) 0 (0%) 2 (0.1%)
Schwalbe’s line and anterior meshwork (1) 5 (0.2%) 3 (0.1%)
Posterior pigmented meshwork (2) 90 (4.3%) 98 (4.7%)
Scleral Spur (3) 797 (37.8%) 809 (38.4%)
Ciliary Band (4) 1219 (57.8%) 1195 (56.7%)
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Table 3
Intraocular Pressure in the Nakuru Eye Disease Cohort
Baseline (whole sample) Baseline who were followed up Follow up
Right Eye
(n=3,745)
Left Eye
(n=3,746)
Right Eye
(n=1,784)
Left Eye
(n=1,776)
Right Eye
(n=1,784)
Left Eye
(n=1,776)
Mean pressure (mmHg) 15.3 14.5 15.4 14.6 15.0 14.9
Sample Standard Deviation 3.4 3.0 3.4 2.9 3.3 3.2
Confidence Interval for Estimate 15.2-15.4 14.4-14.6 15.2-15.6 14.5-14.7 14.9-15.2 14.7-15.0
97.5th Percentile (95% CI) 22.0
(20.0-22.0)
20.0
(20.0-20.0)
22.0
(20.0-23.0)
20.0
(20.0-20.0)
22.0
(21.0-23.0)
21.0
(21.0-22.0)
99.5th Percentile (95% CI) 28.0
(27.0-28.0)
24.0
(23.5-28.0)
28.0
(25.3 -29.9)
25.1
(22.3-27.9)
27.1
(25.0-28.9)
26.0
(24.0-28.9)
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Table 4
Baseline clinical (undilated and dilated) optic disc assessment made at the slit lamp
Undilated assessment Dilated assessment
Right VCDR (95%CI) Left VCDR (95%CI) Right and
Left
(95%CI)
Right VCDR (95%CI) Left VCDR (95%CI) Right and
Left
(95%CI)
Number 2958 2959 5917 3906 3915 7821
0.5th Percentile 0.1(0.1-0.1) 0.1(0.1-0.1) 0.1(0.1-0.1) 0.1(0.1-0.1) 0.1(0.1-0.1) 0.1(0.1-0.1)
2.5th Percentile 0.1(0.1-0.1) 0.1(0.1-0.1) 0.1(0.1-0.1) 0.1(0.1-0.1) 0.1(0.1-0.1) 0.1(0.1-0.1)
Mean(SD) 0.21 (0.14) 0.22 (0.13) 0.21(0.13) 0.23 (0.16) 0.23 (0.15) 0.23(0.15)
97.5th Percentile 0.6(0.5-0.6) 0.6(0.5-0.6) 0.6(0.5-0.6) 0.7(0.6-0.7) 0.6(0.6-0.7) 0.7(0.6-0.7)
99.5th Percentile 0.8(0.8-0.9) 0.8 (0.7-0.9) 0.8(0.8-0.8) 0.9(0.8-1.0) 0.84(0.8-0.9) 0.9(0.8-0.9)
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Table 5
Visual status of participants at follow-up with and without glaucoma
ISGEO Normal vision (≥6/12) [%] Visually impaired (<6/12-3/60) [%] Blind (<3/60) [%]
Negative (N=1972) 1680 [85.2] 269 [13.6] 23 [1.2]
Positive (N=88) 64 [72.7] 19 [21.6] 5 [5.7]
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Table 6
Association of anthropometric risk factors at baseline and ophthalmic risk factors at follow-up with glaucoma
at follow-up (*follow-up risk factor)
Category N total Abnormal Percentage Odds Ratio
Lower 95%
CI limit
Upper 95%
CI limit p-value
Gender Male 989 50 5.1% 1.00
0.10Female 1072 38 3.5% 0.69 0.45 1.06
Location Rural 1559 60 3.8% 1.00
0.13Urban 502 28 5.6% 1.48 0.93 2.34
Socio Economic Status Poorest 464 23 5.0% 1.00
0.53
Poorer 574 20 3.5% 0.69 0.38 1.28
Richer 532 27 5.1% 1.03 0.58 1.81
Richest 480 17 3.5% 0.70 0.37 1.34
Tribe Kikuyu 1336 58 4.3% 1.00
0.19
Kalenjin 507 16 3.2% 0.72 0.41 1.26
Other 218 14 6.4% 1.51 0.83 2.76
BMI Category Underweight 195 9 4.6% 1.00
0.69
Normal 913 36 3.9% 0.85 0.40 1.79
Overweight 540 27 5.0% 1.09 0.50 2.36
Obese 340 12 3.5% 0.76 0.31 1.83
Hypertensive No 1250 54 4.3% 1.00
0.84Yes 799 33 4.1% 0.95 0.61 1.49
Diabetic No 1839 77 4.2% 1.00
0.58Yes 221 11 5.0% 1.20 0.63 2.29
Education level reported None 186 6 3.2% 1.00
0.49
Primary 624 26 4.2% 1.30 0.53 3.22
Secondary 1034 50 4.8% 1.52 0.64 3.61
College/Uni 215 6 2.8% 0.86 0.27 2.72
CCT <=550 1484 55 3.71% 1.00 0.44
>550 160 4 2.50% 0.67 0.24 1.86
RAPD* No 1,831 57 3.11% 1.00
<0.001Yes 99 19 19.19% 7.39 4.20 13.01
IOP* <=21 1,920 75 3.91% 1.00
<0.001>21 77 11 14.29% 4.10 2.08 8.08
Gonioscopy* Open 2040 87 4.26% 1.00 0.28
Occludable 8 1 12.50% 3.21 0.39 26.35
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